MEDINA is a drug discovery organization and a partner site of the European research infrastructure EU-OPENSCREEN (www.eu-openscreen.eu). Leveraging our drug discovery expertise, the potential of our natural product libraries and the high throughput screening and...
News Archive
Discovery of Pancreatic Adenocarcinoma Biomarkers by Untargeted Metabolomics
New article by Fundacion MEDINA in collaboration with the Department of Oncology at the Ludwig Institute for Cancer Research of the University of Lausanne, the Institute of Biopathology and Regenerative Medicine (IBIMER), Center of Biomedical Research (CIBM) of the...
First evidence of anticancer and antimicrobial activity in Mediterranean mesopelagic species.
New article by Fundacion MEDINA in collaboration with the Marine Biotechnology Department at the Stazione Zoologica Anton Dohrn, Naples, and the Department of Chemical, Biological, Pharmaceutical and Environmental Sciences (ChiBioFarAm) of the University of Messina:...
BSP meeting Trypanosomiasis & Leishmaniasis Symposium: Novel Advances in Basic and Applied Research. March 8 – 11, Granada- Spain.
Dr. Freddie Annang, a specialist in drug discovery against parasitic diseases from Fundación MEDINA, attended the BSP meeting entitled “Trypanosomiasis & Leishmaniasis Symposium: Novel Advances in Basic and Applied Research” which took place in Granada from the...
Determination of a group of biomarkers through metabolomics studies that could be a “fingerprint” to diagnose metastatic colon cancer.
Colorectal cancer is one of the main causes of cancer death worldwide, and novel biomarkers are urgently needed for its early diagnosis and treatment. The utilization of metabolomics to identify and quantify metabolites in body fluids may allow the detection of...
V GQB Chembio Group Meeting, February 19-21, Granada- Spain.
Fernando Reyes and Ignacio Pérez-Victoria, from the Chemistry Department of MEDINA, attended the V GQB Chembio Group Meeting celebrated in Granada from the 19th to the 21st of February. Both presented recent results on the combined use of...
LISSA Project: Alternatives to the use of disinfectants in the food industry aimed at reducing the survival of Listeria monocytogenes and Salmonella enterica on surfaces.
Fundación MEDINA participates in the LISSA project, Alternatives to the use of disinfectants in the food industry aimed at reducing the survival of Listeria monocytogenes and Salmonella enterica on the surfaces, coordinated by Dr. Joaquín Venancio Martínez Suárez of...
European RFMF Metabomeeting 2020. January 22-24, Toulouse (France).
Dr José Pérez del Palacio, Caridad Díaz Navarro and Ariadna Martín, from the MEDINA Metabolomics team attended the European RFMF Metabomeeting 2020 in Toulouse (January 22- 24th 2020). Dr José Pérez del Palacio presented our metabolic network analysis tools in...
12th Convention of Biomedical Research of Ghana, July 30 – August 1, Kumasi – Ghana
Dr. Freddie Annang, specialist in parasitic diseases, attended the 12th Convention of Biomedical Research of Ghana from the 30th of July to the 1st of August to discuss Fundación MEDINA’s microbial library, infrastructure and professional expertise for possible...
Natural Products and Bioactive Compounds Gordon Research Conference, July 28 – August 2, 2019, Andover – USA
Dr. Olga Genilloud, Scientific Director of Fundación MEDINA, attended the new Gordon Conference on Natural Products and Bioactive Compounds at the Proctor Academy in Andover, New Hampshire. She contributed to the session on Discovery and Chemistry of new Secondary...